Figure 3.

Frequency of incident and recurrent infections from years 1‐3 posttransplant, by intensity of desensitization. ILDKT recipients were more likely to develop both incident and recurrent infections, particularly those who were highly desensitized. In the second year post–KT, 23.2% of recipients developed an infection; of these, 66.4% were recurrent infections (none = 12.7%, low = 19.1%, moderate = 13.5%, high = 22.3%). In the third year post–KT, 16.6% of recipients developed an infection; of these, 84.8% were recurrent infections (none = 12.7%, low = 10.6%, moderate = 14.9%, high = 19.1%)